Search

everythinglearnresearchcommunity

for

Search:↓

In 2005, hair transplants looked natural and worked best with realistic goals, medication to preserve hair, and depended on the amount of donor hair.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Mesenchymal stem cells help improve wound healing by reducing inflammation and promoting skin cell growth and movement.

Children need early diagnosis and treatment for iron-deficiency anemia to prevent learning problems and promote health.

Hair loss from mood stabilizers can grow back, but the reasons why are not fully understood.

Minoxidil helps stimulate hair growth and enlarge small follicles in common hair loss, but doesn't stop it, and its effects can be boosted when combined with finasteride.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Some nonsurgical hair loss treatments are effective, especially if started early.

Androgen use may increase the risk of stroke, but more research is needed.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Menopause affects hair and skin; more research needed for treatment.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

High concentration Minoxidil and Carboxygas effectively treated resistant hair loss with no side effects.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.